Our data suggest that the altering SET8 expression, which is mediated at least partly by miR-502, could modify the ESCC outcome by inhibiting the proliferation and invasion as well as promoting the apoptosis of ESCC cell. This evidence concerns the gene KMT5A and esophageal squamous cell carcinoma.